COMMUNIQUÉS West-GlobeNewswire

Community Mental Health Association of Michigan Praises Lawsuit Filed to Stop PIHP Bid Process
28/08/2025
LANSING, Mich., Aug. 28, 2025 (GLOBE NEWSWIRE) -- The Community Mental Health Association of Michigan (CMHA) released the following statement today from its CEO Robert Sheehan to applaud the public behavioral health [...]
Surrozen to Present at Upcoming Healthcare Investor Conference
28/08/2025
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt [...]
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
28/08/2025
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for [...]
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
28/08/2025
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living [...]
Cardiff Oncology to Participate in Three Upcoming Investor Conferences
28/08/2025
SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced [...]
Neuphoria Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
28/08/2025
BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments for neuropsychiatric [...]
89bio to Participate in Upcoming Investor Conferences
28/08/2025
SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver [...]
atai Life Sciences to Participate in September Investor Conferences
28/08/2025
NEW YORK and AMSTERDAM, Aug. 28, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health [...]
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
28/08/2025
LONDON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in fireside chats at the following investor conferences in September: [...]
Editas Medicine to Host Webinar Announcing Lead In Vivo Development Candidate
28/08/2025
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it [...]
Nurix Therapeutics to Participate in Upcoming Investor Conferences
28/08/2025
SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]
Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences
28/08/2025
LEXINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel [...]
Ascendis Pharma to Participate in the 2025 Wells Fargo Healthcare Conference
28/08/2025
COPENHAGEN, Denmark, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the 2025 Wells Fargo Healthcare Conference on [...]
Carlsmed® Reports Second Quarter 2025 Financial Results
28/08/2025
Q2’25 revenue of $12.1 million, 99% YOY growth Full year revenue guidance of $45.5M - $47.5M CARLSBAD, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical [...]
Alignment Health CEO Named “Founder of the Year” at 2025 LA Times Studios’ OC Executive Forum & Leadership Awards
28/08/2025
Award recognizes John Kao’s leadership in building a leading Medicare Advantage organization and contributing to Orange County’s business community ORANGE, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Alignment Health [...]
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market
28/08/2025
Strategic Move Positions YD Bio Limited for Accelerated Innovation and Market Expansion Trading of common stock and warrants of the new public company, YD Bio Limited, is expected to commence on the Nasdaq Global Market [...]
Tilray Medical renforce sa présence en Allemagne en introduisant de nouvelles variétés de cannabis thérapeutique Good Supply
28/08/2025
Tilray confirme son engagement constant envers le système de santé allemand et élargit l’accès des patients et des pharmacies au plus grand marché européen du cannabis thérapeutique LONDRES et NEUMÜNSTER, 28 août 2025 ( [...]
Raina Biosciences Unveils Breakthrough Generative AI Platform for mRNA Therapeutics Featured in Science
28/08/2025
– GEMORNA is world’s first generative AI platform purpose-built for mRNA design and optimization, demonstrating state-of-the-art performance across diverse mRNA therapeutic applications – – GEMORNA designs optimized [...]
Cirtec Medical Announces Appointment of New Chief Executive Officer
28/08/2025
BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce [...]

Pages